<VariationArchive VariationID="9534" VariationName="NM_130439.3(MXI1):c.623del (p.Lys208fs)" VariationType="Deletion" Accession="VCV000009534" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="24573" VariationID="9534">
      <GeneList>
        <Gene Symbol="MXI1" FullName="MAX interactor 1, dimerization protein" GeneID="4601" HGNC_ID="HGNC:7534" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q25.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="110207605" stop="110287365" display_start="110207605" display_stop="110287365" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="111967362" stop="112047122" display_start="111967362" display_stop="112047122" Strand="+" />
          </Location>
          <OMIM>600020</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_130439.3(MXI1):c.623del (p.Lys208fs)</Name>
      <CanonicalSPDI>NC_000010.11:110279981:AAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q25.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="110279982" stop="110279982" display_start="110279982" display_stop="110279982" variantLength="1" positionVCF="110279981" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="112039740" stop="112039740" display_start="112039740" display_stop="112039740" variantLength="1" positionVCF="112039739" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>K141fs</ProteinChange>
      <ProteinChange>K208fs</ProteinChange>
      <ProteinChange>K95fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.112039742del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.112039742del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.110279984del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.110279984del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012103.1" sequenceAccession="NG_012103" sequenceVersion="1" change="g.77380del">
            <Expression>NG_012103.1:g.77380del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001008541.1" sequenceAccession="NM_001008541" sequenceVersion="1" change="c.284del">
            <Expression>NM_001008541.1:c.284del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001008541.1" sequenceAccession="NP_001008541" sequenceVersion="1" change="p.Lys95fs">
            <Expression>NP_001008541.1:p.Lys95fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005962.5" sequenceAccession="NM_005962" sequenceVersion="5" change="c.422del">
            <Expression>NM_005962.5:c.422del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005953.4" sequenceAccession="NP_005953" sequenceVersion="4" change="p.Lys141fs">
            <Expression>NP_005953.4:p.Lys141fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130439.3" sequenceAccession="NM_130439" sequenceVersion="3" change="c.623del" MANESelect="true">
            <Expression>NM_130439.3:c.623del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_569157.2" sequenceAccession="NP_569157" sequenceVersion="2" change="p.Lys208fs">
            <Expression>NP_569157.2:p.Lys208fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600020.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_130439.3(MXI1):c.623del (p.Lys208fs) AND Malignant tumor of prostate" Accession="RCV000010142" Version="6">
        <ClassifiedConditionList TraitSetID="2563">
          <ClassifiedCondition DB="MedGen" ID="C0376358">Malignant tumor of prostate</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">7773287</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2563" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5807" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Prostate cancer</ElementValue>
                <XRef ID="HP:0012125" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008315" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Malignant tumor of prostate</ElementValue>
                <XRef ID="Prostate+cancer/9175" DB="Genetic Alliance" />
                <XRef ID="399068003" DB="SNOMED CT" />
              </Name>
              <Citation Type="general" Abbrev="NACB, 2008">
                <ID Source="PubMed">19042984</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2014">
                <ID Source="PubMed">24071797</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="AUA, 2018">
                <ID Source="PubMed">23659877</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Prostate cancer genetics">
                <ID Source="PubMed">26389227</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®), Prostate Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2021">
                <ID Source="PubMed">33497248</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2019">
                <ID Source="PubMed">31829902</ID>
              </Citation>
              <Citation Type="general" Abbrev="HKUA/HKSU-O, 2022">
                <ID Source="PubMed">35924163</ID>
                <ID Source="pmc">9339641</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng12</URL>
                <CitationText>UK NICE Guideline NG12, Suspected cancer: recognition and referral, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng131</URL>
                <CitationText>UK NICE Guideline NG131, Prostate cancer: diagnosis and management, 2021</CitationText>
              </Citation>
              <XRef ID="1331" DB="Orphanet" />
              <XRef ID="C0376358" DB="MedGen" />
              <XRef ID="MONDO:0008315" DB="MONDO" />
              <XRef Type="primary" ID="HP:0012125" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30363" SubmissionDate="2004-08-17" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600020.0001_PROSTATE CANCER" title="MXI1, 1-BP DEL, A, CODON 140 OR 141_PROSTATE CANCER" />
        <ClinVarAccession Accession="SCV000030363" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a prostate cancer (176807) tumor, Eagle et al. (1995) found loss of a single alanine at codon 140 or 141, converting AAG (lys) to AGT (ser) in the ZIP-encoding exon. The frameshift resulted in loss of the terminal leucine residue of the ZIP domain as well as loss of all additional downstream amino acid sequences, including those comprising the last 2 alpha-helical turns of the ZIP domain. This was a presumably inactivating mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">7773287</ID>
              </Citation>
              <XRef DB="OMIM" ID="176807" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MXI1" />
          </GeneList>
          <Name>MXI1, 1-BP DEL, A, CODON 140 OR 141</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, A, CODON 140 OR 141</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600020.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROSTATE CANCER</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="30363" TraitType="Disease" MappingType="Name" MappingValue="PROSTATE CANCER" MappingRef="Preferred">
        <MedGen CUI="C0376358" Name="Malignant tumor of prostate" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>